Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Marie Croft, PhD

Pharmaron ABS, Inc.

Disclosure(s): TenNor Therapeutics (Suzhou) Ltd: Investigator

Poster(s):

(P-1117) An Open-label Phase 1 Study in Healthy Adult Male Participants to Investigate the Absorption, Metabolism, and Excretion of [¹⁴C]-Rifaquizinone Following a Single Intravenous Administration

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT